Symbols / PYPD $4.75 +1.28% PolyPid Ltd.
PYPD Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 89.88M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $4.69 | Price | $4.75 | Change | 1.28% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
- PolyPid (PYPD) Stock Outlook | Q4 2025: Earnings Underperform - Stock Trading Network - Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 20
- When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? - Yahoo Finance Fri, 13 Feb 2026 08
- Drug aimed at preventing surgery infections reaches FDA filing stage - Stock Titan ue, 31 Mar 2026 07
- PYPD Options Chain — NASDAQ:PYPD - TradingView Fri, 10 Apr 2026 13
- Can PolyPid (PYPD) Stock Beat Estimates | Price at $4.24, Down 3.42% - Community Picks - UBND thành phố Hải Phòng Mon, 06 Apr 2026 07
- In a Phase 3 surgery trial, PolyPid's antibiotic released for 32 days - Stock Titan Mon, 13 Apr 2026 07
- PolyPid (PYPD) director submits initial Form 3 ownership - Stock Titan Mon, 06 Apr 2026 07
- PYPD Trades Sideways: Key Levels in Focus - Cổng thông tin điện tử Tỉnh Sơn La Fri, 03 Apr 2026 07
- PolyPid (PYPD) director details vested and future stock options - Stock Titan Mon, 06 Apr 2026 07
- PolyPid (PYPD) CFO details extensive employee stock option awards - Stock Titan Mon, 23 Mar 2026 07
- $4.3M FDA fee waived for new drug to prevent surgical infections - Stock Titan ue, 17 Mar 2026 07
- PolyPid (PYPD) COO details stock option and share holdings - Stock Titan hu, 26 Mar 2026 07
- PolyPid (PYPD) director Dror-Darwish Nir lists six vested option grants - Stock Titan hu, 26 Mar 2026 07
- PolyPid (PYPD) director Barenholz discloses shares and multiple option grants - Stock Titan Mon, 23 Mar 2026 07
- PolyPid (PYPD) director discloses stock options on 17,456 shares - Stock Titan Wed, 18 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
32.97
+17.62%
|
28.03
+22.57%
|
22.87
-41.20%
|
38.89
|
| Research And Development |
|
23.81
+4.37%
|
22.81
+41.26%
|
16.15
-42.31%
|
27.99
|
| Selling General And Administration |
|
9.16
+75.55%
|
5.22
-22.34%
|
6.72
-38.35%
|
10.90
|
| Selling And Marketing Expense |
|
1.98
+109.21%
|
0.94
-20.99%
|
1.20
-58.59%
|
2.89
|
| General And Administrative Expense |
|
7.18
+68.10%
|
4.27
-22.63%
|
5.52
-31.05%
|
8.01
|
| Other Gand A |
|
7.18
+68.10%
|
4.27
-22.63%
|
5.52
-31.05%
|
8.01
|
| Total Expenses |
|
32.97
+17.62%
|
28.03
+22.57%
|
22.87
-41.20%
|
38.89
|
| Operating Income |
|
-32.97
-17.62%
|
-28.03
-22.57%
|
-22.87
+41.20%
|
-38.89
|
| Total Operating Income As Reported |
|
-32.97
-17.62%
|
-28.03
-22.57%
|
-22.87
+41.20%
|
-38.89
|
| EBITDA |
|
-31.83
-23.15%
|
-25.85
-26.98%
|
-20.36
+45.23%
|
-37.17
|
| Normalized EBITDA |
|
-30.99
-19.39%
|
-25.96
-26.09%
|
-20.59
+44.60%
|
-37.17
|
| Reconciled Depreciation |
|
1.46
-10.11%
|
1.62
-10.98%
|
1.82
+5.87%
|
1.72
|
| EBIT |
|
-33.29
-21.19%
|
-27.47
-23.86%
|
-22.18
+42.97%
|
-38.89
|
| Total Unusual Items |
|
-0.84
-841.59%
|
0.11
-51.71%
|
0.23
-56.02%
|
0.53
|
| Total Unusual Items Excluding Goodwill |
|
-0.84
-841.59%
|
0.11
-51.71%
|
0.23
-56.02%
|
0.53
|
| Special Income Charges |
|
-0.51
|
0.00
|
0.00
|
—
|
| Other Special Charges |
|
0.51
|
—
|
—
|
—
|
| Net Income |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Pretax Income |
|
-34.16
-17.89%
|
-28.98
-21.79%
|
-23.80
+39.65%
|
-39.43
|
| Net Non Operating Interest Income Expense |
|
-0.36
+66.26%
|
-1.06
+8.51%
|
-1.16
-115.37%
|
-0.54
|
| Interest Expense Non Operating |
|
0.87
-42.12%
|
1.51
-6.67%
|
1.62
+199.63%
|
0.54
|
| Net Interest Income |
|
-0.36
+66.26%
|
-1.06
+8.51%
|
-1.16
-115.37%
|
-0.54
|
| Interest Expense |
|
0.87
-42.12%
|
1.51
-6.67%
|
1.62
+199.63%
|
0.54
|
| Interest Income Non Operating |
|
0.52
+16.97%
|
0.44
-19.34%
|
0.55
+105.24%
|
0.27
|
| Interest Income |
|
0.52
+16.97%
|
0.44
-19.34%
|
0.55
+105.24%
|
0.27
|
| Other Income Expense |
|
-0.84
-841.59%
|
0.11
-51.71%
|
0.23
-56.02%
|
0.53
|
| Gain On Sale Of Security |
|
-0.33
-388.50%
|
0.11
-51.71%
|
0.23
-56.02%
|
0.53
|
| Tax Provision |
|
0.01
-88.10%
|
0.04
-39.13%
|
0.07
-46.51%
|
0.13
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
-100.00%
|
0.03
-51.71%
|
0.05
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Net Income From Continuing Operation Net Minority Interest |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Net Income From Continuing And Discontinued Operation |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Net Income Continuous Operations |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Normalized Income |
|
-33.33
-14.50%
|
-29.11
-21.06%
|
-24.05
+39.21%
|
-39.56
|
| Net Income Common Stockholders |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
—
|
0.00
|
| Diluted EPS |
|
—
|
-4.91
+71.10%
|
-16.99
+72.10%
|
-60.90
|
| Basic EPS |
|
—
|
-4.91
+71.10%
|
-16.99
+72.10%
|
-60.90
|
| Basic Average Shares |
|
—
|
5.91
+321.04%
|
1.40
+116.87%
|
0.65
|
| Diluted Average Shares |
|
—
|
5.91
+316.02%
|
1.42
+119.49%
|
0.65
|
| Diluted NI Availto Com Stockholders |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Total Other Finance Cost |
|
0.00
+150.00%
|
-0.00
-104.30%
|
0.09
-70.57%
|
0.32
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
15.37
|
| Current Assets |
|
6.07
|
| Cash Cash Equivalents And Short Term Investments |
|
5.31
|
| Cash And Cash Equivalents |
|
5.31
|
| Other Short Term Investments |
|
0.00
|
| Receivables |
|
—
|
| Other Receivables |
|
—
|
| Inventory |
|
—
|
| Prepaid Assets |
|
0.35
|
| Restricted Cash |
|
0.30
|
| Other Current Assets |
|
0.11
|
| Total Non Current Assets |
|
9.30
|
| Net PPE |
|
9.22
|
| Gross PPE |
|
17.02
|
| Accumulated Depreciation |
|
-7.80
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.79
|
| Other Properties |
|
9.72
|
| Leases |
|
6.50
|
| Non Current Prepaid Assets |
|
—
|
| Other Non Current Assets |
|
0.09
|
| Total Liabilities Net Minority Interest |
|
17.47
|
| Current Liabilities |
|
7.29
|
| Payables And Accrued Expenses |
|
2.73
|
| Payables |
|
0.77
|
| Accounts Payable |
|
0.77
|
| Other Payable |
|
—
|
| Current Accrued Expenses |
|
1.95
|
| Current Debt And Capital Lease Obligation |
|
4.54
|
| Current Debt |
|
4.00
|
| Other Current Borrowings |
|
4.00
|
| Current Capital Lease Obligation |
|
0.54
|
| Current Deferred Liabilities |
|
—
|
| Current Deferred Revenue |
|
—
|
| Other Current Liabilities |
|
0.02
|
| Total Non Current Liabilities Net Minority Interest |
|
10.18
|
| Long Term Debt And Capital Lease Obligation |
|
7.24
|
| Long Term Debt |
|
6.38
|
| Long Term Capital Lease Obligation |
|
0.86
|
| Non Current Deferred Liabilities |
|
2.55
|
| Non Current Deferred Revenue |
|
2.55
|
| Other Non Current Liabilities |
|
0.40
|
| Stockholders Equity |
|
-2.10
|
| Common Stock Equity |
|
-2.10
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Share Issued |
|
1.65
|
| Ordinary Shares Number |
|
1.65
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
236.21
|
| Retained Earnings |
|
-238.31
|
| Total Equity Gross Minority Interest |
|
-2.10
|
| Total Capitalization |
|
4.28
|
| Working Capital |
|
-1.22
|
| Invested Capital |
|
8.29
|
| Total Debt |
|
11.78
|
| Net Debt |
|
5.07
|
| Capital Lease Obligations |
|
1.40
|
| Net Tangible Assets |
|
-2.10
|
| Tangible Book Value |
|
-2.10
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-27.88
-26.94%
|
-21.96
-27.43%
|
-17.24
+49.77%
|
-34.32
|
| Cash Flow From Continuing Operating Activities |
|
-27.88
-26.94%
|
-21.96
-27.43%
|
-17.24
+49.77%
|
-34.32
|
| Net Income From Continuing Operations |
|
-34.17
-17.73%
|
-29.02
-21.61%
|
-23.86
+39.67%
|
-39.56
|
| Depreciation Amortization Depletion |
|
1.46
-10.11%
|
1.62
-10.98%
|
1.82
+5.87%
|
1.72
|
| Depreciation |
|
1.46
-10.11%
|
1.62
-10.98%
|
1.82
+5.87%
|
1.72
|
| Depreciation And Amortization |
|
1.46
-10.11%
|
1.62
-10.98%
|
1.82
+5.87%
|
1.72
|
| Other Non Cash Items |
|
-0.89
-228.12%
|
0.70
-59.64%
|
1.73
+497.58%
|
0.29
|
| Stock Based Compensation |
|
4.85
+71.88%
|
2.82
-16.72%
|
3.39
-21.27%
|
4.31
|
| Operating Gains Losses |
|
0.51
|
—
|
-0.20
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
-0.20
|
—
|
| Change In Working Capital |
|
0.36
-81.26%
|
1.92
+1841.82%
|
-0.11
+89.79%
|
-1.08
|
| Change In Prepaid Assets |
|
-0.23
+28.57%
|
-0.32
-149.14%
|
0.64
-45.91%
|
1.19
|
| Change In Payables And Accrued Expense |
|
0.35
-83.47%
|
2.13
+350.59%
|
-0.85
+81.16%
|
-4.51
|
| Change In Accrued Expense |
|
0.17
-65.11%
|
0.49
+202.49%
|
-0.48
+66.03%
|
-1.42
|
| Change In Payable |
|
0.18
-89.00%
|
1.64
+543.63%
|
-0.37
+88.08%
|
-3.10
|
| Change In Account Payable |
|
0.18
-89.00%
|
1.64
+543.63%
|
-0.37
+88.08%
|
-3.10
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
2.55
|
| Change In Other Current Assets |
|
0.91
+10.07%
|
0.82
+38.95%
|
0.59
+124.39%
|
-2.43
|
| Change In Other Current Liabilities |
|
-0.68
+6.64%
|
-0.72
-46.36%
|
-0.49
-123.17%
|
2.13
|
| Investing Cash Flow |
|
-6.70
-1931.52%
|
-0.33
-108.68%
|
3.80
-77.05%
|
16.57
|
| Cash Flow From Continuing Investing Activities |
|
-6.70
-1931.52%
|
-0.33
-108.68%
|
3.80
-77.05%
|
16.57
|
| Net PPE Purchase And Sale |
|
-0.21
-176.32%
|
-0.08
+61.22%
|
-0.20
+88.91%
|
-1.77
|
| Purchase Of PPE |
|
-0.21
-176.32%
|
-0.08
+61.22%
|
-0.20
+88.91%
|
-1.77
|
| Capital Expenditure |
|
-0.21
-176.32%
|
-0.08
+61.22%
|
-0.20
+88.91%
|
-1.77
|
| Net Investment Purchase And Sale |
|
-6.49
-2456.69%
|
-0.25
-106.35%
|
4.00
-78.19%
|
18.34
|
| Purchase Of Investment |
|
-26.22
-22.77%
|
-21.35
-14.80%
|
-18.60
-165.71%
|
-7.00
|
| Sale Of Investment |
|
19.72
-6.53%
|
21.10
-6.64%
|
22.60
-10.82%
|
25.34
|
| Financing Cash Flow |
|
25.37
-21.74%
|
32.42
+224.94%
|
9.98
-39.27%
|
16.43
|
| Cash Flow From Continuing Financing Activities |
|
25.37
-21.74%
|
32.42
+224.94%
|
9.98
-39.27%
|
16.43
|
| Net Issuance Payments Of Debt |
|
-6.38
-91.93%
|
-3.32
-26.89%
|
-2.62
-123.15%
|
11.31
|
| Issuance Of Debt |
|
—
|
0.00
|
0.00
-100.00%
|
11.71
|
| Repayment Of Debt |
|
-6.38
-91.93%
|
-3.32
-26.89%
|
-2.62
-551.24%
|
-0.40
|
| Long Term Debt Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
11.71
|
| Long Term Debt Payments |
|
-6.38
-91.93%
|
-3.32
-26.89%
|
-2.62
-551.24%
|
-0.40
|
| Net Long Term Debt Issuance |
|
-6.38
-91.93%
|
-3.32
-26.89%
|
-2.62
-123.15%
|
11.31
|
| Net Common Stock Issuance |
|
32.60
-9.09%
|
35.86
+182.16%
|
12.71
+153.64%
|
5.01
|
| Proceeds From Stock Option Exercised |
|
0.00
|
0.00
-100.00%
|
0.01
-91.67%
|
0.11
|
| Net Other Financing Charges |
|
-0.86
-587.20%
|
-0.12
+0.00%
|
-0.12
|
—
|
| Changes In Cash |
|
-9.21
-191.02%
|
10.12
+392.91%
|
-3.46
-163.01%
|
-1.31
|
| Beginning Cash Position |
|
15.81
+178.03%
|
5.69
-37.80%
|
9.14
-12.57%
|
10.46
|
| End Cash Position |
|
6.59
-58.28%
|
15.81
+178.03%
|
5.69
-37.80%
|
9.14
|
| Free Cash Flow |
|
-28.09
-27.45%
|
-22.04
-26.43%
|
-17.43
+51.69%
|
-36.08
|
| Interest Paid Supplemental Data |
|
0.56
-41.37%
|
0.95
-8.48%
|
1.04
+41.42%
|
0.73
|
| Income Tax Paid Supplemental Data |
|
0.01
+66.67%
|
0.00
-83.33%
|
0.02
+125.00%
|
0.01
|
| Common Stock Issuance |
|
32.60
-9.09%
|
35.86
+182.16%
|
12.71
+153.64%
|
5.01
|
| Issuance Of Capital Stock |
|
32.60
-9.09%
|
35.86
+182.16%
|
12.71
+153.64%
|
5.01
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|